Continual Improvement of the Reliability of EML4-ALK Rearrangement Detection in Non-Small-Cell Lung Cancer A Long-Term Comparison of ALK Detection in China
Continual Improvement of the Reliability of EML4-ALK Rearrangement Detection in Non-Small-Cell Lung Cancer A Long-Term Comparison of ALK Detection in China
复制标题
DOI:
10.1016/j.jmoldx.2020.03.007
复制
发表时间:
2020-07-01
影响因子:
4.1
通讯作者:
Li,Jinming
中科院分区:
文献类型:
--
作者:
Peng,Rongxue;Zhang,Rui;Li,Jinming
The results ofEML4-ALKtesting are critical to manage ALK tyrosine kinase receptor inhibitor treatment. Thus, the accurate detection ofALKrearrangement is increasingly becoming a matter of serious concern. To address this issue, a long-termEML4-ALKproficiency testing (PT) scheme was launched in China in 2015, serving as an educational tool for assessing and improving the testing quality ofEML4-ALKfusion detection. Responses across 20 different PT samples interrogating three different variants and wild-type samples were collected between 2015 and 2019. Performance was analyzed by evaluating the detection methods, kits, and pre-analytic practices used to further display the landscape of changing conditions of the reliability ofEML4-ALKtesting. During the 5 years, 3224 results reported from 988 laboratories were evaluated, with an overall error rate of 5.36%. Along with an increasing number of participating laboratories, the error rate within each of the different methods showed a significantly downward trend over the years. No obvious differences in the error rates were found regarding the testing methods or kit manufacturers. Moreover, the individual performance of the laboratories improved when they participated in more PT scheme rounds. The data demonstrated that the performance of individual Chinese laboratories forEML4-ALKtesting continuously improved over time by participating PT schemes, regardless of their method. However, care must be taken in standardized operations and validations.